+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Australia Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests

  • PDF Icon

    Report

  • 46 Pages
  • June 2025
  • Region: Australia
  • GlobalData
  • ID: 6108264
Description Jump to:
The “Australia Reproductive Health Diagnostics Market Outlook to 2033” is a comprehensive databook report, covering key market data on the Australia Reproductive Health Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Prenatal Screening and Reproductive Hormones and Proteins Tests

The Australia Reproductive Health Diagnostics Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Reproductive Health Diagnostics Market.
  • Global corporate-level profiles of key companies operating within the Australia Reproductive Health Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Australia Reproductive Health Diagnostics is segmented as follows:

  • Prenatal Screening
  • Reproductive Hormones and Proteins Tests

Reasons to Buy

The Australia Reproductive Health Diagnostics Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Reproductive Health Diagnostics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Reproductive Health Diagnostics Market, Australia
3.1 Reproductive Health Diagnostics Market, Australia, Revenue ($m), 2018-2033
3.1.1 Prenatal Screening Market, Australia, Revenue ($m), by Segment, 2018-2033
3.1.2 Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), by Segment, 2018-2033
3.2 Reproductive Health Diagnostics Market, Australia, Volume (Units), 2018-2033
3.2.1 Prenatal Screening Market, Australia, Volume (Units), by Segment, 2018-2033
3.2.2 Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), by Segment, 2018-2033
3.3 Reproductive Health Diagnostics Market, Australia, Average Price ($), 2018-2033
3.4 Reproductive Health Diagnostics Market, Australia, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in Australia, Reproductive Health Diagnostics Market
4.1 Illumina Inc
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.3 Quidelortho Corp
4.3.1 Company Overview
4.4 Danaher Corp
4.4.1 Company Overview
4.5 Siemens AG
4.5.1 Company Overview
4.6 BGI Genomics Co Ltd
4.6.1 Company Overview
4.7 Abbott Laboratories
4.7.1 Company Overview
5 Reproductive Health Diagnostics Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 HeraMED to Raise USD0.31 Million in Second Tranche Private Placement of Shares
6.1.2 Memphasys Raises USD0.66 Million in Private Placement of Shares
6.1.3 Memphasys Raises USD0.57 Million in Share Purchase Plan (SPP)
7 Recent Developments
7.1 Product News
7.1.1 Sep 23, 2024: Memphasys Files Patent for Novel Antioxidant Assay System, RoXsta
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Reproductive Health Diagnostics Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 2: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 3: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033
Table 4: Reproductive Health Diagnostics Market, Australia, Volume (Units), 2018-2033
Table 5: Prenatal Screening Market, Australia, Volume (Units), 2018-2033
Table 6: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2018-2033
Table 7: Reproductive Health Diagnostics Market, Australia, Average Price ($), 2018-2033
Table 8: Reproductive Health Diagnostics Market, Australia, Company Share by Revenue ($m), 2024
Table 9: Reproductive Health Diagnostics Market Pipeline Products
Table 10: HeraMED to Raise USD0.31 Million in Second Tranche Private Placement of Shares
Table 11: Memphasys Raises USD0.66 Million in Private Placement of Shares
Table 12: Memphasys Raises USD0.57 Million in Share Purchase Plan (SPP)
Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Reproductive Health Diagnostics Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 2: Prenatal Screening Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 3: Reproductive Hormones and Proteins Tests Market, Australia, Revenue ($m), USD Constant, 2018-2033
Figure 4: Reproductive Health Diagnostics Market, Australia, Volume (Units), 2018-2033
Figure 5: Prenatal Screening Market, Australia, Volume (Units), 2018-2033
Figure 6: Reproductive Hormones and Proteins Tests Market, Australia, Volume (Units), 2018-2033
Figure 7: Reproductive Health Diagnostics Market, Australia, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories

Related Topics

Related Reports

Australia Reproductive Health Devices Market Outlook to 2033 - Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others - Product Image

Australia Reproductive Health Devices Market Outlook to 2033 - Assisted Reproductive Technology (ART) Devices, Reversible Contraceptive Devices and Others

  • Report
  • 99 Pages
  • Australia
From
Asia-Pacific Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests - Product Image

Asia-Pacific Reproductive Health Diagnostics Market Outlook to 2033 - Prenatal Screening and Reproductive Hormones and Proteins Tests

  • Report
  • 125 Pages
  • Asia Pacific
From
Women's Health Market Report 2025-2033 - Product Image

Women's Health Market Report 2025-2033

  • Report
  • 133 Pages
  • Global
From
Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, Method, Application, and End User - Forecast, 2024-2033 - Product Image

Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, Method, Application, and End User - Forecast, 2024-2033

  • Report
  • 70 Pages
  • Australia
From
Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033 - Product Image

Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033

  • Report
  • 68 Pages
  • Asia Pacific
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.